Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/29/25 16:16 | 5/27/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Hahn Mark W | X0 | O | CFO | 12 | S.dm | -21,903 | 5.65 | 0 | -3,877 | 14,940 | D | |||||||||||||||
5/29/25 16:15 | 5/27/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Zaccardelli David | X0 | DO | P,CEO | 12 | S.dm | -21,904 | 5.65 | 0 | -3,877 | 15,851 | D | |||||||||||||||
5/22/25 16:06 | 5/20/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Sinha Vikas | X0 | D | 3 | S.d | -3,109 | 9.14 | 0 | -340 | 74 | D | ||||||||||||||||
5/16/25 16:31 | 5/15/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Fisher Andrew | X0 | O | GC | 2 | S.d | -920 | 8.67 | 0 | -106 | 360 | D | |||||||||||||||
5/16/25 16:30 | 5/14/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Ackermann Christina | X0 | D | 1 | S.d | -338 | 8.44 | 0 | -40 | 42 | D | ||||||||||||||||
5/8/25 16:30 | 5/6/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Rickard Kathleen A. | X0 | O | Chief Me | 7 | S.d | -3,753 | 6.36 | 0 | -590 | 2,732 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |